Ocular Therapeutix (OCUL) Tops Q3 EPS by 11c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.39), $0.11 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $477 thousand versus the consensus estimate of $470 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Zurn Water Solutions (ZWS) Reiterated at Buy by Stifel on New Product Development Momentum
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results